Kevin R Flaherty
Professor of Internal Medicine
IRB Vice Chair and Associate Residency Program Director
Medical School
[email protected]
Available to mentor
Kevin R Flaherty
Professor
Manage Your Profile
Recent Publications
-
Shetty S, Swaminathan AC, Li P, Neely ML, Olson AL, Snyder LD, Whelan TPM, Walia R, Veeraraghavan S, Strek ME, Southern B, Liu G, Safdar Z, Russell T, Rosas I, Roman J, Ramaswamy M, Raj R, Porteous M, Paul T, Namen A, Morrison L, Maher TM, Mageto Y, Luckhardt TR, Lobo L, Lipchik R, Pinto-Plata V, Sanchez H, Lasky JA, Hewlett J, Gupta E, Kim HJ, Kebbe J, Kaner RJ, Hotchkin D, Hamblin M, Case AH, Gupta N, Gulati M, Fowler R, Flaherty KR, Fitzgerald J, Bemiss B, Dilling D, Condos R, Chardon D, Belperio JA, Beegle S, Bandyopadhyay D, Baker A. Lung, 2026 Dec 1; 204 (1):Journal ArticleWorkplace Productivity Loss in Patients with Progressive Pulmonary Fibrosis: Data from the ILD-PRO Registry
DOI:10.1007/s00408-026-00895-x PMID: 42201372 -
Cottin V, Brown K, Flaherty KR, Kolb M, Lynch DA, Oldham J, Valenzuela C, Wijsenbeek M, Wells AU. Eur Respir J, 2026 Jun 11;Journal ArticleProgressive pulmonary fibrosis: a state-of-the-art review.
DOI:10.1183/13993003.01557-2025 PMID: 42276742 -
Nathan SD, Behr J, Cottin V, Smith PM, Deng C, Rao Y, Breytenbach N, Bell H, Peterson L, Flaherty KR. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.007Journal ArticleA82-01 TETON-1 Phase 3 Clinical Trial Of Inhaled Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
DOI:10.1093/ajrccm/aamag286.007 -
Nathan SD, Behr J, Cottin V, Smith PM, Deng C, Rao Y, Breytenbach N, Bell H, Peterson L, Flaherty KR. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.180Journal ArticleB95-09 TETON Phase 3 Clinical Trials of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis: Integrated Efficacy and Safety Results for TETON-1 and TETON-2
DOI:10.1093/ajrccm/aamag286.180 -
Nathan SD, Behr J, Cottin V, Smith PM, Deng C, Rao Y, Breytenbach N, Bell H, Peterson L, Flaherty KR. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.189Journal ArticleC103-25 TETON-1 Phase 3 Clinical Trial of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
DOI:10.1093/ajrccm/aamag286.189 -
Nathan SD, Smith P, Deng C, King CS, De Salvo M, Weigt SS, Pandya S, Bandyopadhyay D, Lasky JA, Krishna R, Hambly N, Ramaswamy M, Kebbe J, Ettinger N, Gao J, Rao Y, Breytenbach N, Peterson L, Bell H, Behr J, Cottin V, Flaherty KR, TETON-1 Trial Investigators . N Engl J Med, 2026 May 18;Journal ArticlePhase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.
DOI:10.1056/NEJMoa2501488 PMID: 42149993 -
Wang JM, Pugashetti JV, Murray S, Mohan N, Kang E, Kazerooni E, Flaherty KR, Belloli E, Sheth JS, O’Dwyer DN, Han MK, Hatt CR, Oldham J. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.2203Journal ArticleA15-05 Screening for Interstitial Lung Disease Using Quantitative CT Thresholds
DOI:10.1093/ajrccm/aamag162.2203 -
Wang JM, Pugashetti JV, Murray S, Mohan N, Kang E, Kazerooni E, Flaherty KR, Belloli E, Sheth JS, O’Dwyer DN, Han MK, Hatt CR, Oldham J. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.2446Journal ArticleB23-09 Comparing Survival Outcomes Between Radiomic UIP and Visual UIP Classification in Fibrotic ILD
DOI:10.1093/ajrccm/aamag162.2446
